John Catanzaro – Medium

John Catanzaro

Pinned

John Catanzaro

The Power of Peptides: The Precision Molecules of Life

2021 John A. Catanzaro, CEO of Neo7Logix

Dec 30, 2020

The Power of Peptides: The Precision Molecules of Life

Dec 30, 2020

John Catanzaro

Complicated Reactions of mRNA Vaccines

2021 John A. Catanzaro

Mar 5, 2021

Complicated Reactions of mRNA Vaccines

Mar 5, 2021

John Catanzaro

mRNA Vaccines “No Go” Scenario

2021 John A. Catanzaro

Feb 6, 2021

Feb 6, 2021

John Catanzaro

mRNA Vaccine Related Death By Destruction of Platelets

2021 John A. Catanzaro, CEO of Neo7Logix

Jan 8, 2021

mRNA Vaccine Related Death By Destruction of Platelets

Jan 8, 2021

John Catanzaro

Fueling the Viral Fire With mRNA

2021 John A. Catanzaro, CEO of Neo7Logix

Jan 2, 2021

Fueling the Viral Fire With mRNA

Jan 2, 2021

John Catanzaro

Neo7logix Covid-19 Treatment Reduces Viral Infection By More Than 99% In Preclinical Study

PBIMA-SOLVx COVID-19 May Be The First Highly Effective Treatment for COVID-19, Patent Pending Treatment

Oct 28, 2020

Neo7logix Covid-19 Treatment Reduces Viral Infection By More Than 99% In Preclinical Study

Oct 28, 2020

John Catanzaro

DNA to Personalized Design

2020 John A. Catanzaro

Jul 5, 2020

DNA to Personalized Design

Jul 5, 2020

John Catanzaro

Immunity Vs Vaccine ?

2020 John A. Catanzaro

Jun 6, 2020

Immunity Vs Vaccine ?

Jun 6, 2020

John Catanzaro

Adverse Fever In Healthy People!

2020 John A. Catanzaro

May 28, 2020

Adverse Fever In Healthy People!

May 28, 2020

John Catanzaro

Anti-Viral Vaccine Strategies Therapeutic, Prophylactic Or Challenge; The Best Approach

2020 John A. Catanzaro

May 23, 2020

Anti-Viral Vaccine Strategies Therapeutic, Prophylactic Or Challenge; The Best Approach

May 23, 2020

John Catanzaro

John Catanzaro

John A. Catanzaro is CEO of Neo7logix, a bioscience company that designs precision and personalized treatment designs. www.neo7logix.com

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams